Ignite Creation Date:
2025-12-24 @ 9:46 PM
Ignite Modification Date:
2026-05-26 @ 9:21 AM
Study NCT ID:
NCT03941132
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-02-24
First Post:
2019-05-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Clinical Phase II/III Trial of Ustekinumab to Treat Type 1 Diabetes (UST1D2)
Sponsor:
University of British Columbia
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
H19-00411
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None